Edition:
United Kingdom

Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

6.00USD
17 May 2019
Change (% chg)

$0.11 (+1.87%)
Prev Close
$5.89
Open
$5.84
Day's High
$6.02
Day's Low
$5.78
Volume
4,493
Avg. Vol
13,221
52-wk High
$10.51
52-wk Low
$3.35

About

Merrimack Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in designing novel treatments for cancer by targeting biomarker-defined cancers. Its clinical programs include MM-121 (seribantumab), MM-141 (istiratumab) and MM-310. MM-121 is a fully human monoclonal antibody that binds to the... (more)
No analyst recommendations are available for .

Overall

Beta: 2.36
Market Cap(Mil.): $80.06
Shares Outstanding(Mil.): 13.34
Dividend: --
Yield (%): --

Financials

  MACK.OQ Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -4.00 -- --
ROI: -74.87 7.41 11.59
ROE: -83.21 7.88 16.33

Earnings vs. Estimates